Zurzuvae, the recently FDA-approved pill to treat postpartum depression. (Image: Getty; illustration by Alex Cochran for Yahoo) In August the Food and Drug Administration approved Zurzuvae (zuranolone ...

A new study out of Stanford Medicine has found a “new category of depression” that impacts 27% of diagnosed individuals and is “not effectively” treated by standard antidepressants. Specifically, this ...

For decades, depression treatment has focused almost entirely on the brain, with drugs designed to tweak neurotransmitters ...

Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...

Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...

A new medication called Auvelity was just FDA-approved to treat major depressive disorder (MDD), also known as clinical depression, in as little as one week. The new “fast-acting” oral drug for ...

A new analysis of clinical trial data indicates that psilocybin-assisted psychotherapy provides immediate relief for anxiety ...

Biohaven said on Wednesday its experimental depression drug did not meet the main goal of a mid-stage trial, adding to a string of trial and regulatory setbacks for the drugmaker this year. The ...

If you’re feeling depressed and looking for a solution, there are many options: medications, CBT, DBT, somatic therapy and so much more. However, one recent major study discovered that one treatment — ...

Let's go into some of the barriers to access for women who are suffering from postpartum depression. The barriers are multi. So I don't think that I can kind of even communicate all of them to you ...